{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:29:40Z","timestamp":1768642180075,"version":"3.49.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2003,2,3]],"date-time":"2003-02-03T00:00:00Z","timestamp":1044230400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1038\/sj.npp.1300178","type":"journal-article","created":{"date-parts":[[2003,4,16]],"date-time":"2003-04-16T14:32:40Z","timestamp":1050503560000},"page":"1292-1299","source":"Crossref","is-referenced-by-count":69,"title":["Topiramate Normalizes Hippocampal NPY-LI in Flinders Sensitive Line \u2018Depressed\u2019 Rats and Upregulates NPY, Galanin, and CRH-LI in the Hypothalamus: Implications for Mood-Stabilizing and Weight Loss-Inducing Effects"],"prefix":"10.1038","volume":"28","author":[{"given":"Henriette","family":"Husum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"van Kammen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien","family":"Termeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom G","family":"Bolwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksander A","family":"Math\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,2,3]]},"reference":[{"key":"BF1300178_CR1","first-page":"329","volume":"149","author":"S Amano","year":"1996","unstructured":"Amano S, Ihara N, Uemura S, Yokoyama M, Ikeda M, Serikawa T et al (1996). Development of a novel rat mutant with spontaneous limbic-like seizures. Am J Pathol 149: 329\u2013336.","journal-title":"Am J Pathol"},{"key":"BF1300178_CR2","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0006-2952(02)00883-3","volume":"63","author":"AS Attele","year":"2002","unstructured":"Attele AS, Shi ZQ, Yuan CS (2002). Leptin, gut and food intake. Biochem Pharmacol 63: 1579\u20131783.","journal-title":"Biochem Pharmacol"},{"key":"BF1300178_CR3","doi-asserted-by":"publisher","first-page":"8927","DOI":"10.1523\/JNEUROSCI.17-23-08927.1997","volume":"17","author":"SC Baraban","year":"1997","unstructured":"Baraban SC, Hollopeter G, Erickson JC, Schwartzkroin PA, Palmiter RD (1997). Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J Neurosci 17: 8927\u20138936.","journal-title":"J Neurosci"},{"key":"BF1300178_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0304-3940(01)02446-6","volume":"317","author":"I Bellido","year":"2002","unstructured":"Bellido I, Diaz-Cabiale Z, Jim\u00e9nez Vasquez PA, Andbjer B, Math\u00e9 AA, Fuxe K (2002). Increased density of galanin binding sites in the dorsal raphe in a genetic rat model of depression. Neurosci Lett 317: 101\u2013105.","journal-title":"Neurosci Lett"},{"key":"BF1300178_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4088\/JCP.v62n0112f","volume":"62","author":"JL Berlant","year":"2001","unstructured":"Berlant JL (2001). Topiramate in posttraumatic stress disorder: preliminary clinical observations. J Clin Psychiatry 62: 60\u201363.","journal-title":"J Clin Psychiatry"},{"key":"BF1300178_CR6","first-page":"93","volume":"15","author":"TG Bolwig","year":"1999","unstructured":"Bolwig TG, Woldbye DP, Mikkelsen JD (1999). Electroconvulsive therapy as an anticonvulsant: a possible role of neuropeptide Y (NPY). JECT 15: 93\u2013101.","journal-title":"JECT"},{"key":"BF1300178_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0165-3806(98)00130-8","volume":"111","author":"KL Brunson","year":"1998","unstructured":"Brunson KL, Schultz L, Baram TZ (1998). The in vivo proconvulsant effects of corticotropin releasing hormone in the developing rat are independent of ionotropic glutamate receptor activitation. Dev Brain Res 111: 119\u2013128.","journal-title":"Dev Brain Res"},{"key":"BF1300178_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/00004714-200106000-00015","volume":"21","author":"JR Calabrese","year":"2001","unstructured":"Calabrese JR, Keck PE, McElroy SL, Shelton MD (2001). A pilot study of topiramate as monotherapy in the treatment of acute mania. J Clin Psychopharmacol 21: 340\u2013342.","journal-title":"J Clin Psychopharmacol"},{"key":"BF1300178_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0304-3940(00)01137-X","volume":"287","author":"S DePrato Primeaux","year":"2000","unstructured":"DePrato Primeaux S, Holmes PV, Martin RJ, Dean RG, Edwards GL (2000). Experimentally induced attenuation of neuropeptide-Y gene expression in transgenic mice increases mortality rate following seizures. Neurosci Lett 287: 61\u201364.","journal-title":"Neurosci Lett"},{"key":"BF1300178_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/381415a0","volume":"381","author":"JC Erickson","year":"1996","unstructured":"Erickson JC, Clegg KE, Palmiter RD (1996). Sensitivity to leptin and susceptibility to seizure of mice lacking neuropeptide Y. Nature 381: 415\u2013418.","journal-title":"Nature"},{"key":"BF1300178_CR11","first-page":"23","volume":"17","author":"A Gjerris","year":"1992","unstructured":"Gjerris A, Widerl\u00f6v E, Werdelin L, Ekman R (1992). Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls. J Psychiatry Neurosci 17: 23\u201327.","journal-title":"J Psychiatry Neurosci"},{"key":"BF1300178_CR12","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1016\/0024-3205(87)90465-6","volume":"41","author":"DA Haas","year":"1987","unstructured":"Haas DA, George SR (1987). Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions. Life Sci 41: 2725\u20132731.","journal-title":"Life Sci"},{"key":"BF1300178_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2174\/1389450013348209","volume":"2","author":"JC Halford","year":"2001","unstructured":"Halford JC (2001). Pharmacology of appetite suppression: implication for the treatment of obesity. Curr Drug Targets 2: 353\u2013370.","journal-title":"Curr Drug Targets"},{"key":"BF1300178_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0304-3940(96)13008-1","volume":"216","author":"H Hashimoto","year":"1996","unstructured":"Hashimoto H, Onishi H, Koide S, Kai T, Yamagami S (1996). Plasma neuropeptide Y in patients with major depressive disorder. Neurosci Lett 216: 57\u201360.","journal-title":"Neurosci Lett"},{"key":"BF1300178_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/BF00441953","volume":"98","author":"M Heilig","year":"1989","unstructured":"Heilig M, S\u00f6derpalm B, Engel JA, Widerl\u00f6v E (1989). Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology 98: 425\u2013429.","journal-title":"Psychopharmacology"},{"key":"BF1300178_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/0006-8993(93)91771-J","volume":"611","author":"SC Heinrichs","year":"1993","unstructured":"Heinrichs SC, Menzaghi F, Pich EM, Koob GF (1993). Corticotropin-releasing factor in paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res 611: 18\u201324.","journal-title":"Brain Res"},{"key":"BF1300178_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","volume":"23","author":"F Holsboer","year":"2000","unstructured":"Holsboer F (2000). The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23: 477\u2013501.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300178_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0893-133X(00)00198-6","volume":"24","author":"H Husum","year":"2001","unstructured":"Husum H, Jim\u00e9nez Vasquez PA, Math\u00e9 AA (2001). Changed concentrations of tachykinins and neuropeptide Y in brain of a rat model of depression. Lithium treatment normalizes tachykinins. Neuropsychopharmacology 24: 183\u2013191.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300178_CR19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0893-133X(02)00363-9","volume":"27","author":"H Husum","year":"2002","unstructured":"Husum H, Math\u00e9 AA (2002). Early life stress affects concentrations of neuropeptide Y and corticotropin-releasing hormone in adult rat brain. Lithium treatment affects these changes. Neuropsychopharmacology 27: 757\u2013764.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300178_CR20","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/S0028-3908(00)00009-5","volume":"39","author":"H Husum","year":"2000","unstructured":"Husum H, Mikkelsen JD, Hogg S, Math\u00e9 AA, Mork A (2000). Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram. Neuropharmacology 39: 1463\u20131473.","journal-title":"Neuropharmacology"},{"key":"BF1300178_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-8993(97)01374-7","volume":"781","author":"H Husum","year":"1998","unstructured":"Husum H, Mikkelsen JD, M\u00f8rk A (1998). Extracellular levels of neuropeptide Y are markedly increased in the dorsal hippocampus of freely moving rats during kainic acid-induced seizures. Brain Res 781: 351\u2013354.","journal-title":"Brain Res"},{"key":"BF1300178_CR22","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S0028-3908(02)00038-2","volume":"42","author":"H Husum","year":"2002","unstructured":"Husum H, Termeer E, Math\u00e9 AA, Cools AR, Ellenbroek BA (2002). Early maternal deprivation alters hippocampal levels of neuropeptide Y and calcitonin-gene related peptide in adult rats. Neuropharmacology 42: 798\u2013806.","journal-title":"Neuropharmacology"},{"key":"BF1300178_CR23","first-page":"29","volume":"16","author":"DS Janowsky","year":"1980","unstructured":"Janowsky DS, Risch C, Parker D, Huey L, Judd L (1980). Increased vulnerability to cholinergic stimulation in affective disorder patients. Psychopharmacol Bull 16: 29\u201331.","journal-title":"Psychopharmacol Bull"},{"key":"BF1300178_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0165-3806(01)00264-4","volume":"131","author":"PA Jim\u00e9nez Vasquez","year":"2001","unstructured":"Jim\u00e9nez Vasquez PA, Math\u00e9 AA, Thomas JD, Riley EP, Ehlers CL (2001). Early maternal separation alters neuropeptide Y concentrations in selected brain regions in adult rats. Dev Brain Res 131: 149\u2013152.","journal-title":"Dev Brain Res"},{"key":"BF1300178_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0022-3956(00)00036-4","volume":"34","author":"PA Jim\u00e9nez Vasquez","year":"2000","unstructured":"Jim\u00e9nez Vasquez PA, Overstreet DH, Math\u00e9 AA (2000). Neuropeptide Y in male and female brains of flinders sensitive line, a rat model of depression. Effects of electroconvulsive stimuli. J Psychiatry Res 34: 405\u2013412.","journal-title":"J Psychiatry Res"},{"key":"BF1300178_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S0006-8993(99)01510-3","volume":"833","author":"S Jinde","year":"1999","unstructured":"Jinde S, Masui A, Morinobu S, Takahashi Y, Tsunashima K, Noda A et al (1999). Elevated neuropeptide Y and corticotropin-releasing factor in the brain of a novel epileptic mutant rat: Noda epileptic rat. Brain Res 833: 286\u2013290.","journal-title":"Brain Res"},{"key":"BF1300178_CR27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1046\/j.1471-4159.1999.0730641.x","volume":"73","author":"PJ King","year":"1999","unstructured":"King PJ, Widdowson PS, Doods HN, Williams G (1999). Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices. J Neurochem 73: 641\u2013646.","journal-title":"J Neurochem"},{"key":"BF1300178_CR28","doi-asserted-by":"publisher","first-page":"14006","DOI":"10.1073\/pnas.231496298","volume":"98","author":"M Kokaia","year":"2001","unstructured":"Kokaia M, Holmberg K, Nanobashvili A, Xu ZQ, Kokaia Z, Lendahl U et al (2001). Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin. Proc Natl Acad Sci 98: 14006\u201314011.","journal-title":"Proc Natl Acad Sci"},{"key":"BF1300178_CR29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0361-9230(86)90233-9","volume":"17","author":"DD Krahn","year":"1986","unstructured":"Krahn DD, Gosnell BA, Grace M, Levine AS (1986). CRF antagonist partially reverses CRF- and stress-induced effects on feeding. Brain Res Bull 17: 285\u2013289.","journal-title":"Brain Res Bull"},{"key":"BF1300178_CR30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1054\/npep.1999.0776","volume":"33","author":"R Krysiak","year":"1999","unstructured":"Krysiak R, Obuchowicz E, Herman ZS (1999). Diazepam and buspirone alter neuropeptide Y-like immunoreactivity in rat brain. Neuropeptides 33: 542\u2013549.","journal-title":"Neuropeptides"},{"key":"BF1300178_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1054\/npep.2000.0804","volume":"34","author":"R Krysiak","year":"2000","unstructured":"Krysiak R, Obuchowicz E, Herman ZS (2000). Conditioned fear-induced changes in neuropeptide Y-like immunoreactivity in rats: the effect of diazepam and buspirone. Neuropeptides 34: 148\u2013157.","journal-title":"Neuropeptides"},{"key":"BF1300178_CR32","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/0196-9781(90)90023-X","volume":"11","author":"SE Kyrkouli","year":"1990","unstructured":"Kyrkouli SE, Stanley BG, Seirafi RD, Leibowitz SF (1990). Stimulation of feeding by galanin: anatomical localization and behavioral specificity of this peptide's effects in the brain. Peptides 11: 995\u20131001.","journal-title":"Peptides"},{"key":"BF1300178_CR33","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1111\/j.1528-1157.1999.tb00884.x","volume":"40","author":"M Lambert","year":"1999","unstructured":"Lambert M, Robertson M (1999). Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia 40: S21\u2013S47.","journal-title":"Epilepsia"},{"key":"BF1300178_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0167-0115(86)90206-5","volume":"14","author":"EA Linton","year":"1986","unstructured":"Linton EA, Lowry PJ (1986). Comparison of a specific two-site immunoradiometric assay with radioimmunoassay for rat\/human CRF-41. Regul Pept 14: 69\u201384.","journal-title":"Regul Pept"},{"key":"BF1300178_CR35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1046\/j.1365-2826.2000.00451.x","volume":"12","author":"S Makino","year":"2000","unstructured":"Makino S, Baker RA, Smith MA, Gold PW (2000). Differential regulation of neuropeptide Y mRNA expression in the arcuate nucleus and locus coeruleus by stress and antidepressants. J Neuroendocrinology 12: 387\u2013395.","journal-title":"J Neuroendocrinology"},{"key":"BF1300178_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0165-0327(98)00110-4","volume":"50","author":"D Marcotte","year":"1998","unstructured":"Marcotte D (1998). Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Disord 50: 245\u2013251.","journal-title":"J Affect Disord"},{"key":"BF1300178_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0278-5846(98)00023-2","volume":"22","author":"AA Math\u00e9","year":"1998","unstructured":"Math\u00e9 AA, Jim\u00e9nez PA, Theodorsson E, Stenfors C (1998). Neuropeptide Y, neurokinin A and neurotensin in brain regions of fawn hooded \u201cdepressed\u201d, Wistar and Sprague\u2013Dawley rats. Effects of electroconvulsive stimuli. Prog Neuropsychopharmacol Biol Psychiatry 22: 529\u2013546.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BF1300178_CR38","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/depr.3050030505","volume":"3","author":"AA Math\u00e9","year":"1996","unstructured":"Math\u00e9 AA, Rudorfer MV, Stenfors C, Manji HK, Potter WZ, Theodorsson E (1996). Effects of electroconvulsive treatment on somatostatin, neuropeptide Y, endothelin, and neurokinin A concentrations in cerebrospinal fluid of depressed patients: a pilot study. Depression 3: 250\u2013256.","journal-title":"Depression"},{"key":"BF1300178_CR39","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0006-3223(99)00316-9","volume":"47","author":"SL McElroy","year":"2000","unstructured":"McElroy SL, Suppes T, Keck PE, Frye MA, Denicoff KD, Altshuler LL et al (2000). Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry 47: 1025\u20131033.","journal-title":"Biol Psychiatry"},{"key":"BF1300178_CR40","first-page":"274","volume":"5","author":"T Nakajima","year":"2001","unstructured":"Nakajima T, Post RM, Pert A, Ketter TA, Weiss SR (2001). Perspectives on the mechanism of action of electroconvulsive therapy: anticonvulsant, peptidergic, and c-fos proto-oncogene effects. Convulsive Ther 5: 274\u2013295.","journal-title":"Convulsive Ther"},{"key":"BF1300178_CR41","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/0196-9781(96)00013-7","volume":"17","author":"C Nilsson","year":"1996","unstructured":"Nilsson C, Karlsson G, Blennow K, Heilig M, Ekman R (1996). Differences in the neuropeptide Y-like immunoreactivity of the plasma and platelets of human volunteers and depressed patients. Peptides 17: 359\u2013362.","journal-title":"Peptides"},{"key":"BF1300178_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0149-7634(05)80230-1","volume":"17","author":"DH Overstreet","year":"1993","unstructured":"Overstreet DH (1993). The Flinders sensitive line rats: a genetic animal model of depression. Neurosci Biobehav Rev 17: 51\u201368.","journal-title":"Neurosci Biobehav Rev"},{"key":"BF1300178_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/BF00491972","volume":"65","author":"DH Overstreet","year":"1979","unstructured":"Overstreet DH, Russell RW, Helps SC, Messenger M (1979). Selective breeding for sensitivity to the anticholinesterase DFP. Psychopharmacology (Berl) 65: 15\u201320.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300178_CR44","first-page":"87","volume":"4","author":"MJ Owens","year":"1991","unstructured":"Owens MJ, Overstreet DH, Knight DL, Rezvani AH, Ritchie JC, Bissette G et al (1991). Alterations in the hypothalamic\u2013pituitary\u2013adrenal axis in a proposed animal model of depression with genetic muscarinic supersensitivity. Neuropsychopharmacology 4: 87\u201393.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300178_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1046\/j.1528-1157.2001.00510.x","volume":"42","author":"A Piazzini","year":"2001","unstructured":"Piazzini A, Canger R (2001). Depression and anxiety in patients with epilepsy. Epilepsia 42: 29\u201331.","journal-title":"Epilepsia"},{"key":"BF1300178_CR46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1528-1157.1984.tb04181.x","volume":"25","author":"RM Post","year":"1984","unstructured":"Post RM, Putnam FW, Contel NR, Goldman B (1984). Electroconvulsive seizures inhibit amygdala kindling: implications for mechanisms of action in affective illness. Epilepsia 25: 234\u2013239.","journal-title":"Epilepsia"},{"key":"BF1300178_CR47","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/0031-9384(93)90351-F","volume":"54","author":"O Pucilowski","year":"1993","unstructured":"Pucilowski O, Overstreet DH, Rezvani AH, Janowsky DS (1993). Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression. Physiol Behav 54: 1215\u20131220.","journal-title":"Physiol Behav"},{"key":"BF1300178_CR48","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1523\/JNEUROSCI.19-12-05016.1999","volume":"19","author":"J Radulovic","year":"1999","unstructured":"Radulovic J, Ruhmann A, Liepold T, Spiess J (1999). Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J Neurosci 19: 5016\u20135025.","journal-title":"J Neurosci"},{"key":"BF1300178_CR49","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0893-133X(01)00403-1","volume":"26","author":"JP Redrobe","year":"2002","unstructured":"Redrobe JP, Dumont Y, Fournier A, Quirion R (2002). The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology 26: 615\u2013624.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300178_CR50","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1528-1157.2000.tb00176.x","volume":"41","author":"E Reissmuller","year":"2000","unstructured":"Reissmuller E, Ebert U, Loscher W (2000). Anticonvulsant efficacy of topiramate in phenytoin-resistant kindled rats. Epilepsia 41: 372\u2013379.","journal-title":"Epilepsia"},{"key":"BF1300178_CR51","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/0091-3057(82)90466-X","volume":"17","author":"RW Russell","year":"1982","unstructured":"Russell RW, Overstreet DH, Messenger M, Helps SC (1982). Selective breeding for sensitivity to DFP: generalization of effects beyond criterion variables. Pharmacol Biochem Behav 17: 885\u2013891.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300178_CR52","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/0024-3205(95)00302-M","volume":"57","author":"M Sadamatsu","year":"1995","unstructured":"Sadamatsu M, Kanai H, Masui A, Serikawa T, Yamada J, Sasa M et al (1995). Altered brain contents of neuropeptides in spontaneously epileptic rats (SER) and tremour rats with absence seizures. Life Sci 57: 523\u2013531.","journal-title":"Life Sci"},{"key":"BF1300178_CR53","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/0361-9230(92)90267-2","volume":"28","author":"GD Schiller","year":"1992","unstructured":"Schiller GD, Pucilowski O, Wienicke C, Overstreet DH (1992). Immobility-reducing effects of antidepressants in a genetic animal model of depression. Brain Res Bull 28: 821\u2013823.","journal-title":"Brain Res Bull"},{"issue":"Suppl 1","key":"BF1300178_CR54","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","volume":"41","author":"RP Shank","year":"2000","unstructured":"Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE (2000). An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 41(Suppl 1): S3\u2013S9.","journal-title":"Epilepsia"},{"key":"BF1300178_CR55","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0361-9230(85)90100-5","volume":"14","author":"BG Stanley","year":"1985","unstructured":"Stanley BG, Chin AS, Leibowitz SF (1985). Feeding and drinking elicited by central injection of neuropeptide Y: evidence for a hypothalamic site(s) of action. Brain Res Bull 14: 521\u2013524.","journal-title":"Brain Res Bull"},{"key":"BF1300178_CR56","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/jnr.490240315","volume":"24","author":"C Stenfors","year":"1989","unstructured":"Stenfors C, Theodorsson E, Math\u00e9 AA (1989). Effect of repeated electroconvulsive treatment on regional concentrations of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y, and galanin in rat brain. J Neurosci Res 24: 445\u2013450.","journal-title":"J Neurosci Res"},{"key":"BF1300178_CR57","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1016\/S0014-2999(99)00800-6","volume":"387","author":"KA Stogner","year":"2000","unstructured":"Stogner KA, Holmes PV (2000). Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats. Eur J Pharmacol 387: R9\u2013R10.","journal-title":"Eur J Pharmacol"},{"key":"BF1300178_CR58","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/296659a0","volume":"296","author":"K Tatemoto","year":"1982","unstructured":"Tatemoto K, Carlquist M, Mutt V (1982). Neuropeptide Y\u2014a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296: 659\u2013660.","journal-title":"Nature"},{"key":"BF1300178_CR59","doi-asserted-by":"publisher","first-page":"12852","DOI":"10.1073\/pnas.220232997","volume":"97","author":"A Thorsell","year":"2000","unstructured":"Thorsell A, Michalkiewicz M, Dumont Y, Quirion R, Caberlotto L, Rimondini R et al (2000). Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci USA 97: 12852\u201312857.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1300178_CR60","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0006-8993(87)90176-4","volume":"417","author":"C Wahlestedt","year":"1987","unstructured":"Wahlestedt C, Skagerberg G, Ekman R, Heilig M, Sundler F, H\u00e5kanson R (1987). Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res 417: 33\u201338.","journal-title":"Brain Res"},{"key":"BF1300178_CR61","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1749-6632.1998.tb10707.x","volume":"863","author":"JM Weiss","year":"1998","unstructured":"Weiss JM, Bonsall RW, Demetrikopoulos MK, Emery MS, West CHK (1998). Galanin: a significant role in depression. Ann NY Acad Sci 863: 354\u2013382.","journal-title":"Ann NY Acad Sci"},{"key":"BF1300178_CR62","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0924-977X(98)00026-1","volume":"9","author":"A Westrin","year":"1999","unstructured":"Westrin A, Ekman R, Traskman-Bendz L (1999). Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt. Eur Neuropsychopharmacol 9: 205\u2013211.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BF1300178_CR63","first-page":"S77","volume":"52","author":"PS Widdowson","year":"1989","unstructured":"Widdowson PS, Halaris AE (1989). Increased levels of neuropeptide Y\u2014immunoreactivity in rat brain limbic structures following antidepressant treatment. J Neurochem 52: S77.","journal-title":"J Neurochem"},{"key":"BF1300178_CR64","first-page":"572","volume":"9","author":"E Widerl\u00f6v","year":"1986","unstructured":"Widerl\u00f6v E, Wahlestedt C, H\u00e5kanson R, Ekman R (1986). Altered brain neuropeptide function in psychiatric illnesses\u2014with special emphasis on NPY and CRF in major depression. Clin Neuropharmacol 9: 572\u2013574.","journal-title":"Clin Neuropharmacol"},{"key":"BF1300178_CR65","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0167-0115(98)00079-2","volume":"75\u201376","author":"DP Woldbye","year":"1998","unstructured":"Woldbye DP (1998). Antiepileptic effects of NPY on pentylenetetrazole seizures. Regul Pept 75\u201376: 279\u2013282.","journal-title":"Regul Pept"},{"key":"BF1300178_CR66","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nm0797-761","volume":"3","author":"DP Woldbye","year":"1997","unstructured":"Woldbye DP, Larsen PJ, Mikkelsen JD, Klemp K, Madsen TM, Bolwig TG (1997). Powerful inhibition of kainic acid induced seizures by neuropeptide Y via Y5-like receptors. Nat Med 3: 761\u2013764.","journal-title":"Nat Med"},{"key":"BF1300178_CR67","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/0006-8993(96)00730-5","volume":"737","author":"DP Woldbye","year":"1996","unstructured":"Woldbye DP, Madsen TM, Larsen PJ, Mikkelsen JD, Bolwig TG (1996). Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res 737: 162\u2013168.","journal-title":"Brain Res"},{"key":"BF1300178_CR68","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0306-4522(96)00533-7","volume":"78","author":"HC Wu","year":"1997","unstructured":"Wu HC, Chen KY, Lee WY, Lee EH (1997). Antisense oligonucleotides to corticotropin-releasing factor impair memory retention and increase exploration in rats. Neuroscience 78: 147\u2013153.","journal-title":"Neuroscience"},{"key":"BF1300178_CR69","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/(SICI)1096-9861(19980309)392:2<227::AID-CNE6>3.0.CO;2-4","volume":"392","author":"ZQ Xu","year":"1998","unstructured":"Xu ZQ, Shi TJ, Hokfelt T (1998). Galanin\/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors. J Comp Neurol 392: 227\u2013251.","journal-title":"J Comp Neurol"},{"key":"BF1300178_CR70","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0301-0082(00)00018-6","volume":"62","author":"G Yadid","year":"2000","unstructured":"Yadid G, Nakash R, Deri I, Tamar G, Kinor N, Gispan I et al (2000). Elucidation of the neurobiology of depression: insights from a novel genetic animal model. Prog Neurobiol 62: 353\u2013378.","journal-title":"Prog Neurobiol"},{"key":"BF1300178_CR71","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S0899-9007(00)00451-2","volume":"16","author":"DA York","year":"2000","unstructured":"York DA, Singer L, Thomas S, Bray GA (2000). Effect of topiramate on body weight and body composition of Osborne\u2013Mendel rats fed a high-fat diet: alterations in hormones, neuropeptide and uncoupling-protein mRNAs. Nutrition 16: 967\u2013975.","journal-title":"Nutrition"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300178","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:43:55Z","timestamp":1684219435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,3]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["BF1300178"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300178","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2,3]]}}}